← back to search

Emmanuelle Le Chatelier

Université Paris-Saclay · FR
Area of research
Molecular Biology · Physiology
Research interest
Research interests include Gut microbiota and health, Diet and metabolism studies, Clostridium difficile and Clostridium perfringens research, and Bacterial Genetics and Biotechnology.
h-index
36
citations
18,457
works
108
NIH funding
primary concept
Biology
email

Recent publications

Toxic microbiome and progression of chronic kidney disease: insights from a longitudinal CKD-Microbiome Study
Gut 2025cited by 28position: middledoi
Transient colonizing microbes promote gut dysbiosis and functional impairment
npj Biofilms and Microbiomes 2024cited by 28position: middledoi
A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers
Science 2023cited by 210position: middledoi
Evidence of a causal and modifiable relationship between kidney function and circulating trimethylamine N-oxide
Nature Communications 2023cited by 61position: middledoi
Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer
Nature Medicine 2022cited by 624position: middledoi
Microbiome and metabolome features of the cardiometabolic disease spectrum
Nature Medicine 2022cited by 275position: middledoi
Impairment of gut microbial biotin metabolism and host biotin status in severe obesity: effect of biotin and prebiotic supplementation on improved metabolism
Gut 2022cited by 130position: middledoi
Increasing the diversity of dietary fibers in a daily-consumed bread modifies gut microbiota and metabolic profile in subjects at cardiometabolic risk
Gut Microbes 2022cited by 69position: middledoi
Alteration of Gut Microbiome in Patients With Schizophrenia Indicates Links Between Bacterial Tyrosine Biosynthesis and Cognitive Dysfunction
Biological Psychiatry Global Open Science 2022cited by 57position: middledoi
Combinatorial, additive and dose-dependent drug–microbiome associations
Nature 2021cited by 234position: middledoi
Rifaximin-α reduces gut-derived inflammation and mucin degradation in cirrhosis and encephalopathy: RIFSYS randomised controlled trial
Journal of Hepatology 2021cited by 211position: middledoi
Multifaceted modes of action of the anticancer probiotic Enterococcus hirae
Cell Death and Differentiation 2021cited by 49position: middledoi
Statin therapy is associated with lower prevalence of gut microbiota dysbiosis
Nature 2020cited by 511position: middledoi
Microbial ecology perturbation in human IgA deficiency
Science Translational Medicine 2018cited by 269position: middledoi
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
Science 2017cited by 5,354position: middledoi
Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
Science 2017cited by 4,620position: middledoi
Towards standards for human fecal sample processing in metagenomic studies
Nature Biotechnology 2017cited by 889position: middledoi
Quantitative metagenomics reveals unique gut microbiome biomarkers in ankylosing spondylitis
Genome biology 2017cited by 396position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

S. Dusko Ehrlich · Queen Mary University of London4 papers (2017–2025) · 3 papers (2021–2022) · 3 papers (2022–2025)Nicolas Pons · AgroParisTech3 papers (2021–2022) · 2 papers (2022–2024)Susie Guilly · Centre Hospitalier Universitaire de La Réunion2 papers (2021–2022)Sunjae Lee · King's College London2 papers (2021–2024)Saeed Shoaie · King's College London2 papers (2021–2024)Yongsheng Fan · Dalian Medical University1 papers (2017–2017)Dawei Wang · SciTech Development (United States)1 papers (2017–2017)Torben Hansen · Novo Nordisk Foundation1 papers (2022–2022)Yun Huang · Hebei Medical University1 papers (2017–2017) · 1 papers (2024–2024)Zhijun Zheng · BGI Group (China)1 papers (2017–2017) · 1 papers (2017–2017)Bérengère Benoit · Université Claude Bernard Lyon 11 papers (2025–2025)Kenneth D. Bruce · King's College London1 papers (2021–2021)Céline Lange · Université Paris-Sud1 papers (2025–2025)Hugo Roume · Université Paris-Saclay1 papers (2022–2022)Denis Fouque · Université Claude Bernard Lyon 11 papers (2025–2025)